Seroprevalence of hepatitis B and C viruses and some possible associated factors among cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A cross-sectional study.
Tadesse AtanawGetu GirmayAragaw ZemeneMuluneh AssefaTewodros EshetieGezahegn BewketFikadu AlemiyeDebaka BeleteNega BirhanePublished in: PloS one (2024)
In this study, the prevalence of HCV was higher and the HBV prevalence was intermediate in cancer patients. To reduce the burden of HBV and HCV infections, it is crucial to provide access to HBV and HCV screening services, strengthen vaccination, and improve prompt treatment in cancer patients.